Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - CASH FROM OPERATIONS
Cash from Operations ANAB - AnaptysBio, Inc.
-121 M
LAST VALUE
-62.19%
2 YEAR CAGR
-20.02%
5 YEAR CAGR
-35.49%
10 YEAR CAGR